Peer-influenced content. Sources you trust. No registration required. This is HCN.

Annals of Internal MedicineCardiology: What You May Have Missed in 2025

A year‑in‑review article from Annals of Internal Medicine highlights key cardiovascular studies published in 2025 that have implications for clinicians managing common conditions such as hypertension, heart failure, coronary disease, and atrial fibrillation. The review emphasizes areas where treatment paradigms and diagnostic strategies are evolving.


Clinical Considerations

  • The review notes shifts in hypertension management, heart failure therapy, and anticoagulation strategies for atrial fibrillation reported during 2025.
  • Several topics relevant to everyday cardiology practice are addressed, including:
    • Selection of initial imaging in patients with suspected coronary artery disease
    • Re‑evaluation of routine β‑blocker use after myocardial infarction
    • Considerations for invasive vs conservative management in older patients with MI
  • The article also highlights emerging therapies in more specialized areas, such as obstructive hypertrophic cardiomyopathy and advanced lipid‑lowering strategies.
  • A review of data on coffee consumption in atrial fibrillation suggests it may be safer than previously believed, addressing a common patient concern.

Clinical Practice Impact

  • Practice awareness: The review helps clinicians identify areas where evidence may be shifting, prompting reconsideration of long‑held assumptions.
  • Generalist–specialist alignment: Topics emphasize coordination between internal medicine clinicians and cardiology subspecialists in acute and chronic care decisions.
  • Patient counseling: Findings related to lifestyle factors (e.g., coffee intake in AF) may support more nuanced patient discussions.
  • Next steps: Clinicians may wish to seek out the original studies for deeper appraisal before changing practice.

More in Heart Failure

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form